Brooks Laboratories Live BSE/NSE | Brooks Laboratories Fundamenta data | Brooks Laboratories Balance sheet | Brooks Laboratories Quarterly Results | Brooks Laboratories Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

161.93
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

187.28
N/A
1.64

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.87
-2.72
7.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-15.18

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
20.86

P:E (Median)

8 Years
5 Years
3 Years

3.34
-
-

P:BV (Average)

8 Years
5 Years
3 Years

1.01
1.01
1.01

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-12.55
-22.56
-22.90

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 29.24 14.15 106.64% 12.47 16.82 -25.86% 18.82 15.16 24.14% 19.89 15.10 31.72%
Expenses 23.89 16.08 48.57% 12.71 16.95 -25.01% 19.67 17.58 11.89% 20.84 15.98 30.41%
EBITDA 5.35 -1.93 - -0.25 -0.13 - -0.85 -2.42 - -0.95 -0.89 -
EBIDTM 18.30% -13.66% -1.98% -0.74% -4.50% -16.00% -4.76% -5.88%
Other Income 0.52 0.07 642.86% 0.11 0.07 57.14% 0.20 2.46 -91.87% 0.06 0.10 -40.00%
Interest 0.80 0.80 0.00% 0.78 0.83 -6.02% 0.89 0.72 23.61% 0.86 0.77 11.69%
Depreciation 1.71 1.60 6.88% 1.98 1.57 26.11% 1.90 1.61 18.01% 1.63 1.69 -3.55%
PBT 3.36 -4.26 - -2.89 -2.46 - -3.43 -2.30 - -3.37 -3.25 -
Tax 0.00 -2.38 - 0.00 1.28 -100.00% 12.53 4.64 170.04% -0.56 -1.10 -
PAT 3.36 -1.88 - -2.89 -3.73 - -15.96 -6.94 - -2.81 -2.15 -
PATM 11.51% -13.27% -23.16% -22.19% -84.77% -45.80% -14.10% -14.21%
EPS 1.36 -0.76 - -1.17 -1.51 - -6.46 -2.81 - -1.14 -0.87 -

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 29.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 23.89 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 5.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 18.30% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.52 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 1.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 3.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 3.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 11.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 1.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 80.42 69.69 55.03 55.71 57.54 80.01 85.21 85.27 80.11 56.08 52.54 Net Sales Growth 31.34% 26.64% -1.22% -3.18% -28.08% -6.10% -0.07% 6.44% 42.85% 6.74% Cost Of Goods Sold 50.39 46.82 39.43 39.38 36.66 52.95 60.65 58.55 57.35 36.17 -0.47 Gross Profit 30.03 22.86 15.59 16.34 20.88 27.07 24.57 26.72 22.77 19.90 53.01 GP Margin 37.34% 32.80% 28.33% 29.33% 36.29% 33.83% 28.83% 31.34% 28.42% 35.49% 100.89% Total Expenditure 77.11 73.61 63.39 64.64 52.50 68.93 78.46 76.75 69.61 45.61 43.27 Power & Fuel Cost - 2.90 2.56 3.62 1.54 2.05 2.62 2.61 0.80 0.72 0.72 % Of Sales - 4.16% 4.65% 6.50% 2.68% 2.56% 3.07% 3.06% 1.00% 1.28% 1.37% Employee Cost - 11.16 10.04 9.65 6.16 5.20 3.75 2.56 1.74 2.73 2.39 % Of Sales - 16.01% 18.24% 17.32% 10.71% 6.50% 4.40% 3.00% 2.17% 4.87% 4.55% Manufacturing Exp. - 3.95 3.59 3.88 1.69 2.12 2.27 2.00 1.52 1.27 38.63 % Of Sales - 5.67% 6.52% 6.96% 2.94% 2.65% 2.66% 2.35% 1.90% 2.26% 73.52% General & Admin Exp. - 4.73 3.99 4.46 3.24 3.03 2.48 1.99 1.97 2.38 1.77 % Of Sales - 6.79% 7.25% 8.01% 5.63% 3.79% 2.91% 2.33% 2.46% 4.24% 3.37% Selling & Distn. Exp. - 0.95 0.73 1.03 1.82 2.05 4.89 6.82 6.24 2.34 0.24 % Of Sales - 1.36% 1.33% 1.85% 3.16% 2.56% 5.74% 8.00% 7.79% 4.17% 0.46% Miscellaneous Exp. - 3.09 3.05 2.61 1.39 1.54 1.81 2.21 0.00 0.00 0.24 % Of Sales - 4.43% 5.54% 4.68% 2.42% 1.92% 2.12% 2.59% 0% 0% 0.02% EBITDA 3.30 -3.92 -8.36 -8.93 5.04 11.08 6.75 8.52 10.50 10.47 9.27 EBITDA Margin 4.10% -5.62% -15.19% -16.03% 8.76% 13.85% 7.92% 9.99% 13.11% 18.67% 17.64% Other Income 0.89 0.41 2.88 0.24 0.12 1.56 2.36 0.01 0.01 0.92 0.13 Interest 3.33 3.35 2.96 2.40 1.01 0.79 0.44 0.12 0.11 1.56 1.49 Depreciation 7.22 6.65 6.50 6.45 1.67 1.16 1.10 0.83 0.81 0.66 0.60 PBT -6.33 -13.51 -14.95 -17.53 2.48 10.69 7.57 7.57 9.58 9.17 7.30 Tax 11.97 10.86 -0.14 -3.72 0.82 0.19 0.88 0.33 2.44 0.33 0.30 Tax Rate -189.10% -80.38% 0.94% 21.22% 33.06% 1.76% 8.50% 4.36% 25.47% 3.60% 4.17% PAT -18.30 -24.38 -14.81 -13.81 1.67 10.63 9.47 7.24 7.14 8.84 6.89 PAT before Minority Interest -18.30 -24.38 -14.81 -13.81 1.67 10.63 9.47 7.24 7.14 8.84 6.89 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -22.76% -34.98% -26.91% -24.79% 2.90% 13.29% 11.11% 8.49% 8.91% 15.76% 13.11% PAT Growth 0.00% -64.62% -7.24% -926.95% -84.29% 12.25% 30.80% 1.40% -19.23% 28.30% Unadjusted EPS -7.41 -9.87 -6.00 -5.59 0.68 4.30 3.83 2.93 2.89 3.58 2.79

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

80.42

69.69

55.03

55.71

57.54

80.01

85.21

85.27

80.11

56.08

52.54

Net Sales Growth

31.34%

26.64%

-1.22%

-3.18%

-28.08%

-6.10%

-0.07%

6.44%

42.85%

6.74%

Cost Of Goods Sold

50.39

46.82

39.43

39.38

36.66

52.95

60.65

58.55

57.35

36.17

-0.47

Gross Profit

30.03

22.86

15.59

16.34

20.88

27.07

24.57

26.72

22.77

19.90

53.01

GP Margin

37.34%

32.80%

28.33%

29.33%

36.29%

33.83%

28.83%

31.34%

28.42%

35.49%

100.89%

Total Expenditure

77.11

73.61

63.39

64.64

52.50

68.93

78.46

76.75

69.61

45.61

43.27

Power & Fuel Cost

2.90

2.56

3.62

1.54

2.05

2.62

2.61

0.80

0.72

% Of Sales

4.16%

4.65%

6.50%

2.68%

2.56%

3.07%

3.06%

1.00%

1.28%

1.37%

Employee Cost

11.16

10.04

9.65

6.16

5.20

3.75

2.56

1.74

2.73

2.39

% Of Sales

16.01%

18.24%

17.32%

10.71%

6.50%

4.40%

3.00%

2.17%

4.87%

4.55%

Manufacturing Exp.

3.95

3.59

3.88

1.69

2.12

2.27

2.00

1.52

1.27

38.63

% Of Sales

5.67%

6.52%

6.96%

2.94%

2.65%

2.66%

2.35%

1.90%

2.26%

73.52%

General & Admin Exp.

4.73

3.99

4.46

3.24

3.03

2.48

1.99

1.97

2.38

1.77

% Of Sales

6.79%

7.25%

8.01%

5.63%

3.79%

2.91%

2.33%

2.46%

4.24%

3.37%

Selling & Distn. Exp.

0.95

0.73

1.03

1.82

2.05

4.89

6.82

6.24

2.34

0.24

% Of Sales

1.36%

1.33%

1.85%

3.16%

2.56%

5.74%

8.00%

7.79%

4.17%

0.46%

Miscellaneous Exp.

3.09

3.05

2.61

1.39

1.54

1.81

2.21

0.00

0.24

% Of Sales

4.43%

5.54%

4.68%

2.42%

1.92%

2.12%

2.59%

0.02%

EBITDA

3.30

-3.92

-8.36

-8.93

5.04

11.08

6.75

8.52

10.50

10.47

9.27

EBITDA Margin

4.10%

-5.62%

-15.19%

-16.03%

8.76%

13.85%

7.92%

9.99%

13.11%

18.67%

17.64%

Other Income

0.89

0.41

2.88

0.24

0.12

1.56

2.36

0.01

0.92

0.13

Interest

3.33

3.35

2.96

2.40

1.01

0.79

0.44

0.12

0.11

1.56

1.49

Depreciation

7.22

6.65

6.50

6.45

1.67

1.16

1.10

0.83

0.81

0.66

0.60

PBT

-6.33

-13.51

-14.95

-17.53

2.48

10.69

7.57

9.58

9.17

7.30

Tax

11.97

10.86

-0.14

-3.72

0.82

0.19

0.88

0.33

2.44

0.33

0.30

Tax Rate

-189.10%

-80.38%

0.94%

21.22%

33.06%

1.76%

8.50%

4.36%

25.47%

3.60%

4.17%

PAT

-18.30

-24.38

-14.81

-13.81

1.67

10.63

9.47

7.24

7.14

8.84

6.89

PAT before Minority Interest

-18.30

-24.38

-14.81

-13.81

1.67

10.63

9.47

7.24

7.14

8.84

6.89

Minority Interest

0.00

PAT Margin

-22.76%

-34.98%

-26.91%

-24.79%

2.90%

13.29%

11.11%

8.49%

8.91%

15.76%

13.11%

PAT Growth

0.00%

-64.62%

-7.24%

-926.95%

-84.29%

12.25%

30.80%

1.40%

-19.23%

28.30%

Unadjusted EPS

-7.41

-9.87

-6.00

-5.59

0.68

4.30

3.83

2.93

2.89

3.58

2.79

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 98.42 105.15 114.47 128.28 122.05 111.42 112.29 105.41 91.26 19.43 Share Capital 24.70 16.19 16.19 16.19 16.19 16.19 16.19 16.19 16.19 9.89 Total Reserves 73.71 83.41 98.29 112.09 105.86 95.23 96.10 89.22 75.08 9.54 Non-Current Liabilities 13.65 4.43 6.97 5.24 6.14 1.99 2.20 1.87 1.71 1.92 Secured Loans 11.40 13.86 16.63 10.73 0.34 0.00 0.00 0.00 0.00 0.90 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.72 1.48 1.08 1.51 4.34 0.66 0.61 0.49 0.49 0.00 Current Liabilities 45.80 47.39 40.48 24.26 27.92 22.14 17.97 24.38 13.79 19.52 Trade Payables 26.07 27.14 26.65 18.36 15.72 19.04 16.02 12.85 7.24 7.01 Other Current Liabilities 6.56 5.34 4.95 3.60 5.61 1.80 1.74 3.13 1.13 0.73 Short Term Borrowings 12.61 14.47 8.54 2.18 5.28 0.51 0.14 1.09 0.99 7.76 Short Term Provisions 0.56 0.44 0.35 0.13 1.31 0.78 0.08 7.31 4.43 4.01 Total Liabilities 157.87 156.97 161.92 157.78 156.11 135.55 132.46 131.66 106.76 40.87 Net Block 112.35 117.25 124.01 125.31 16.34 15.68 20.15 20.65 22.12 19.09 Gross Block 131.60 131.80 132.11 126.99 23.02 21.34 24.67 24.36 25.02 21.33 Accumulated Depreciation 19.25 14.54 8.10 1.67 6.68 5.65 4.52 3.71 2.90 2.24 Non Current Assets 119.95 125.23 131.23 135.91 126.18 80.76 74.48 62.44 61.95 23.96 Capital Work in Progress 0.78 0.29 0.52 0.00 86.86 52.86 37.16 35.52 33.88 0.63 Non Current Investment 0.02 0.47 0.65 0.65 0.02 0.02 0.02 0.02 0.02 0.02 Long Term Loans & Adv. 6.68 7.04 5.93 9.95 22.96 12.20 17.15 6.25 5.93 3.79 Other Non Current Assets 0.11 0.18 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.43 Current Assets 37.92 31.74 30.70 21.87 29.94 54.78 54.70 65.94 41.54 16.91 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 13.78 10.05 11.41 7.70 6.69 7.53 6.03 4.98 5.16 5.50 Sundry Debtors 15.56 11.42 10.18 10.69 18.91 19.29 16.46 21.68 10.76 6.96 Cash & Bank 1.53 3.32 1.96 1.84 2.23 22.92 29.99 23.87 19.64 0.87 Other Current Assets 7.06 6.41 6.68 0.77 2.11 5.03 2.22 15.40 5.98 3.58 Short Term Loans & Adv. 0.64 0.54 0.45 0.88 1.89 0.30 0.74 6.57 5.57 3.56 Net Current Assets -7.88 -15.65 -9.79 -2.39 2.02 32.64 36.73 41.56 27.75 -2.61 Total Assets 157.87 156.97 161.93 157.78 156.12 135.54 132.47 131.67 106.76 40.87

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

98.42

105.15

114.47

128.28

122.05

111.42

112.29

105.41

91.26

19.43

Share Capital

24.70

16.19

9.89

Total Reserves

73.71

83.41

98.29

112.09

105.86

95.23

96.10

89.22

75.08

9.54

Non-Current Liabilities

13.65

4.43

6.97

5.24

6.14

1.99

2.20

1.87

1.71

1.92

Secured Loans

11.40

13.86

16.63

10.73

0.34

0.00

0.90

Unsecured Loans

0.00

Long Term Provisions

1.72

1.48

1.08

1.51

4.34

0.66

0.61

0.49

0.00

Current Liabilities

45.80

47.39

40.48

24.26

27.92

22.14

17.97

24.38

13.79

19.52

Trade Payables

26.07

27.14

26.65

18.36

15.72

19.04

16.02

12.85

7.24

7.01

Other Current Liabilities

6.56

5.34

4.95

3.60

5.61

1.80

1.74

3.13

1.13

0.73

Short Term Borrowings

12.61

14.47

8.54

2.18

5.28

0.51

0.14

1.09

0.99

7.76

Short Term Provisions

0.56

0.44

0.35

0.13

1.31

0.78

0.08

7.31

4.43

4.01

Total Liabilities

157.87

156.97

161.92

157.78

156.11

135.55

132.46

131.66

106.76

40.87

Net Block

112.35

117.25

124.01

125.31

16.34

15.68

20.15

20.65

22.12

19.09

Gross Block

131.60

131.80

132.11

126.99

23.02

21.34

24.67

24.36

25.02

21.33

Accumulated Depreciation

19.25

14.54

8.10

1.67

6.68

5.65

4.52

3.71

2.90

2.24

Non Current Assets

119.95

125.23

131.23

135.91

126.18

80.76

74.48

62.44

61.95

23.96

Capital Work in Progress

0.78

0.29

0.52

0.00

86.86

52.86

37.16

35.52

33.88

0.63

Non Current Investment

0.02

0.47

0.65

0.02

Long Term Loans & Adv.

6.68

7.04

5.93

9.95

22.96

12.20

17.15

6.25

5.93

3.79

Other Non Current Assets

0.11

0.18

0.12

0.00

0.43

Current Assets

37.92

31.74

30.70

21.87

29.94

54.78

54.70

65.94

41.54

16.91

Current Investments

0.00

Inventories

13.78

10.05

11.41

7.70

6.69

7.53

6.03

4.98

5.16

5.50

Sundry Debtors

15.56

11.42

10.18

10.69

18.91

19.29

16.46

21.68

10.76

6.96

Cash & Bank

1.53

3.32

1.96

1.84

2.23

22.92

29.99

23.87

19.64

0.87

Other Current Assets

7.06

6.41

6.68

0.77

2.11

5.03

2.22

15.40

5.98

3.58

Short Term Loans & Adv.

0.64

0.54

0.45

0.88

1.89

0.30

0.74

6.57

5.57

3.56

Net Current Assets

-7.88

-15.65

-9.79

-2.39

2.02

32.64

36.73

41.56

27.75

-2.61

Total Assets

157.87

156.97

161.93

157.78

156.12

135.54

132.47

131.67

106.76

40.87

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -9.39 -5.04 -6.18 9.56 8.12 2.13 10.65 5.39 -0.82 3.96 PBT -13.51 -14.95 -17.53 2.48 10.69 7.57 7.57 9.58 9.17 7.30 Adjustment 11.76 9.24 9.83 3.26 0.67 -0.66 0.88 0.89 1.24 0.66 Changes in Working Capital -7.62 1.22 2.31 5.55 2.15 -3.98 3.94 -2.64 -10.90 -5.31 Cash after chg. in Working capital -9.38 -4.48 -5.40 11.29 13.51 2.92 12.39 7.83 -0.49 2.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.01 -0.56 -0.78 -1.73 -5.39 -1.66 -1.73 -2.44 -0.33 1.31 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.87 0.00 0.00 0.00 0.00 Cash From Investing Activity -2.33 1.12 -5.14 -16.80 -13.56 -1.12 -10.64 -1.32 -41.02 -0.84 Net Fixed Assets -0.29 0.54 -5.64 -17.11 -35.68 -12.37 -1.95 -0.98 -36.94 -0.92 Net Investments 0.45 0.18 0.00 -0.63 0.00 0.00 0.00 0.00 0.00 0.00 Others -2.49 0.40 0.50 0.94 22.12 11.25 -8.69 -0.34 -4.08 0.08 Cash from Financing Activity 9.61 5.78 11.82 7.01 4.32 -0.07 0.29 0.16 60.61 -3.10 Net Cash Inflow / Outflow -2.10 1.85 0.51 -0.23 -1.12 0.94 0.31 4.23 18.77 0.01 Opening Cash & Equivalents 2.50 0.65 0.14 0.37 1.49 0.55 0.24 19.64 0.87 0.86 Closing Cash & Equivalent 0.40 2.50 0.65 0.14 0.37 1.49 0.55 23.87 19.64 0.87

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-9.39

-5.04

-6.18

9.56

8.12

2.13

10.65

5.39

-0.82

3.96

PBT

-13.51

-14.95

-17.53

2.48

10.69

7.57

9.58

9.17

7.30

Adjustment

11.76

9.24

9.83

3.26

0.67

-0.66

0.88

0.89

1.24

0.66

Changes in Working Capital

-7.62

1.22

2.31

5.55

2.15

-3.98

3.94

-2.64

-10.90

-5.31

Cash after chg. in Working capital

-9.38

-4.48

-5.40

11.29

13.51

2.92

12.39

7.83

-0.49

2.65

Interest Paid

0.00

Tax Paid

-0.01

-0.56

-0.78

-1.73

-5.39

-1.66

-1.73

-2.44

-0.33

1.31

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

0.87

0.00

Cash From Investing Activity

-2.33

1.12

-5.14

-16.80

-13.56

-1.12

-10.64

-1.32

-41.02

-0.84

Net Fixed Assets

-0.29

0.54

-5.64

-17.11

-35.68

-12.37

-1.95

-0.98

-36.94

-0.92

Net Investments

0.45

0.18

0.00

-0.63

0.00

Others

-2.49

0.40

0.50

0.94

22.12

11.25

-8.69

-0.34

-4.08

0.08

Cash from Financing Activity

9.61

5.78

11.82

7.01

4.32

-0.07

0.29

0.16

60.61

-3.10

Net Cash Inflow / Outflow

-2.10

1.85

0.51

-0.23

-1.12

0.94

0.31

4.23

18.77

0.01

Opening Cash & Equivalents

2.50

0.65

0.14

0.37

1.49

0.55

0.24

19.64

0.87

0.86

Closing Cash & Equivalent

0.40

2.50

0.65

0.14

0.37

1.49

0.55

23.87

19.64

0.87

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 39.84 51.31 58.97 66.08 62.87 57.40 56.15 52.61 45.33 16.39 ROA -15.48% -9.29% -8.64% 1.06% 7.29% 7.06% 5.48% 5.99% 11.97% 17.63% ROE -24.62% -13.83% -11.38% 1.33% 9.11% 8.59% 6.86% 7.52% 16.45% 41.71% ROCE -7.77% -8.60% -10.64% 2.59% 9.69% 9.76% 7.24% 10.09% 18.33% 32.43% Fixed Asset Turnover 0.53 0.42 0.44 0.86 3.61 3.70 3.48 3.26 2.43 2.51 Receivable days 70.66 71.64 66.94 83.32 87.15 76.58 81.63 73.59 57.45 53.25 Inventory Days 62.40 71.18 61.28 40.49 32.44 29.05 23.57 23.01 34.56 35.11 Payable days 126.51 149.31 121.22 121.35 94.73 84.10 69.81 53.16 58.29 70.62 Cash Conversion Cycle 6.54 -6.50 7.00 2.46 24.87 21.53 35.39 43.44 33.72 17.74 Total Debt/Equity 0.27 0.31 0.24 0.11 0.05 0.00 0.00 0.01 0.01 0.45 Interest Cover -3.03 -4.05 -6.29 3.46 14.62 24.34 64.73 84.79 6.89 5.81

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

39.84

51.31

58.97

66.08

62.87

57.40

56.15

52.61

45.33

16.39

ROA

-15.48%

-9.29%

-8.64%

1.06%

7.29%

7.06%

5.48%

5.99%

11.97%

17.63%

ROE

-24.62%

-13.83%

-11.38%

1.33%

9.11%

8.59%

6.86%

7.52%

16.45%

41.71%

ROCE

-7.77%

-8.60%

-10.64%

2.59%

9.69%

9.76%

7.24%

10.09%

18.33%

32.43%

Fixed Asset Turnover

0.53

0.42

0.44

0.86

3.61

3.70

3.48

3.26

2.43

2.51

Receivable days

70.66

71.64

66.94

83.32

87.15

76.58

81.63

73.59

57.45

53.25

Inventory Days

62.40

71.18

61.28

40.49

32.44

29.05

23.57

23.01

34.56

35.11

Payable days

126.51

149.31

121.22

121.35

94.73

84.10

69.81

53.16

58.29

70.62

Cash Conversion Cycle

6.54

-6.50

7.00

2.46

24.87

21.53

35.39

43.44

33.72

17.74

Total Debt/Equity

0.27

0.31

0.24

0.11

0.05

0.00

0.01

0.45

Interest Cover

-3.03

-4.05

-6.29

3.46

14.62

24.34

64.73

84.79

6.89

5.81

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 533543 | NSE: BROOKS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Brooks Laboratories Ltd.

Pharmaceuticals & Drugs

BSE: 533543 | NSE: BROOKS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update